HIN 0.00% $2.37 heartware international, inc

deal for full production? joint deal, page-3

  1. 2,120 Posts.
    This is a terrific announcement, teaming up with an German innovative leader to make even better technological products for the future. Heartware clients, will gain more user satisfaction, doing away with the cumbersome main wire line and battery. And the company should gain more market share and competitive advantage, over its competitors..I am looking forward to the next 2 years, where HIN, will gain even more market share/ growth across its emerging growth market of 22 countries.. This is one to watch and Im sure shareholders will be rewarded many times over in the future, if it gains full FDA approval. Sneaky feeling this could be bigger than Cochlear one day...

    DYOR

 
watchlist Created with Sketch. Add HIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.